Skip to Main Content

Paper Details

SDHx mutations and temozolomide in malignant pheochromocytoma and paraganglioma.
Endocr Relat Cancer
8
2022
Malignant pheochromocytomas, PGLs, PHEOs, SDHx, SDHx mutations, Solid Tumors, TMZ, malignant PHEOs, malignant pheochromocytoma, paraganglioma, paragangliomas, patients, succinate, succinate dehydrogenase, temozolomide, tumor, tumors
Author NameAffiliation
Jason L HornickHarvard Medical School
Jason L HornickBrigham and Women's Hospital
Edward D EsplinInvitae Corporation
Edward D EsplinInvitae Corporation
Jennifer A ChanDana-Farber Cancer Institute
Jennifer A ChanHarvard Medical School
Jennifer A ChanDana-Farber Cancer Institute
Jennifer A ChanHarvard Medical School
  • 1 - 8

Datasets

Release 1.2